Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Humira
Generic name / active ingredient
adalimumab
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Subcutaneous injection
Record reviewed
2026-08-17

Copy from the pack in hand

Source-linked reading points

  • The image on this page is only for HUMIRA PEN 40 mg/0.4 mL, two single-dose prefilled pens. Read 40 mg and 0.4 mL together as one product identity; “two pens” is the carton quantity, not an automatic statement of an individual schedule or number of uses.
  • The same label lists 80 mg/0.8 mL, 40 mg/0.8 mL, 40 mg/0.4 mL, 20 mg/0.2 mL and 10 mg/0.1 mL presentations. The same mg number does not prove that the device, volume, package or regimen is the same; do not self-convert, split, combine or switch cartons from that fact.
  • Prefilled pens and prefilled glass syringes are separately listed product presentations in the label. A similar photograph, matching name or the same subcutaneous route does not show that devices are interchangeable, may be opened, made up or administered by another person; use the actual prescription, product instructions and required training.
  • The label includes major warnings such as serious infections and malignancy, and lists boundaries involving other biologic products and live vaccines. Fever, infection symptoms, exposure history, vaccination plans and every current medicine need review by the responsible team; a webpage cannot decide when an individual injects, pauses, combines or changes treatment.

Reviewed presentation examples — compare every field

  • Adalimumab 40 mg/0.4 mL per single-dose prefilled pen; fixed 29-gauge needle; 2 pens per cartonNDC 0074-0554-02

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-17
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image